Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Werner von Siemens

Siemens Healthineers AG

Guane emerging technologies offers solutions for industry 4.0, focusing on artificial intelligence to enhance efficiency, agility, and automation of business operations. Guane creates software supported by applied research and aims to drive innovation and digital transformation in various sectors, including energy, logistics, and legal.

guane emerging technologies

Expert Vision Health provides comprehensive eye care solutions, integrating traditional Chinese medicine with modern medical advancements to offer various treatments and services.

Expert Vision Health

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Metric
Company Name	Siemens Healthineers AG	guane emerging technologies	Expert Vision Health	Avanos Medical, Inc.
Symbol	SHL			AVNS
MSH ID	COM:SIEMENS-HEALTHINEERS	CO:COM:GUANE	COM:89OT	COM:AVANOS
Market	STOCKS	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare	Technology	Healthcare & Health Services	Healthcare
Industry	Medical - Devices	Software Development	Ophthalmology	Medical - Devices
Country	DE	CO	CN	US
Stage
Employee Count	71K			3.77K
Website	siemens-healthineers.com	guane.com.co	89ot.com	avanos.com
LinkedIn		guaneai
Founders

Metric
Market Cap	63.81B		890.08M
Enterprise Value
Monthly Web Traffic	1.01M	165
Web Traffic Growth	-0.14	-0.70
Valuation
Raised Capital	2.50M

Metric
Revenue	23.62B	673.30M
Revenue (LTM)
Revenue (NTM)
Gross Profit	8.94B	382.70M
EBITDA	4.46B	98.50M
Operating Income	3.03B	52.40M
Net Income	2.05B	-61.80M
EPS	1.84	-1.33
Diluted EPS	1.84	-1.33
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.38	0.57
Operating Profit Margin	0.13	0.07
EBITDA Margin	0.19	0.15
Net Profit Margin	0.08	0.02
Return on Equity	0.10	0.01
Return on Assets	0.04	0.01
Return on Capital Employed	0.08	0.03

COM:SIEMENS-HEALTHINEERS

Siemens Healthineers AG

Last Close

49.80

25/11 09:24

Market Cap

60.40B

Beta: -

Volume Today

50.39K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	38.55	-15.55
P/B Ratio	3.22	0.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.83	1.66
EV Multiple	16.20	13.78

Metric
Days Sales Outstanding	136.10	70.67
Days Payables Outstanding	57.55	56.73
Days Inventory Outstanding	125.45	205.17
Operating Cycle	232.75	275.64
Cash Conversion Cycle	179.79	205.02
Asset Turnover	0.48	0.42

Metric
Operating Cash Flow	2.61B	32.40M
Free Cash Flow	1.87B	14.60M
Cash Flow to Debt	3.53	0.33
Operating Cash Flow/Sales	0.11	0.09
Free Cash Flow Yield	0.02	0.04

Metric
Cash & Equivalents	2.83B	87.70M
Accounts Receivable	-445.73M	39M
Inventory	4.41B	163.20M
Goodwill	18.66B	796.10M
Debt to Capitalization	0.47	0.15
Debt to Assets	0.01	0.18
Current Ratio	1.05	3.07
Quick Ratio	0.89	1.49

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.02
R&D to Revenue	0.09	0.04
SG&A to Revenue	0.17